|
Volumn 2, Issue 1, 2011, Pages 38-43
|
Evaluation of FR901464 analogues in vitro and in vivo
|
Author keywords
[No Author keywords available]
|
Indexed keywords
BORTEZOMIB;
DOXORUBICIN;
MEAYAMYCIN;
MEAYAMYCIN B;
MEAYAMYCIN C;
NATURAL PRODUCT;
PACLITAXEL;
UNCLASSIFIED DRUG;
ANIMAL EXPERIMENT;
ANIMAL MODEL;
ANTINEOPLASTIC ACTIVITY;
ARTICLE;
CELL STRAIN HCT116;
CELL STRAIN MCF 7;
COLON TUMOR;
CONTROLLED STUDY;
DRUG BLOOD LEVEL;
DRUG DOSE COMPARISON;
DRUG ELIMINATION;
DRUG GLUCURONIDATION;
DRUG HALF LIFE;
DRUG TOLERABILITY;
FEMALE;
GROWTH INHIBITION;
HUMAN;
HUMAN CELL;
IN VITRO STUDY;
IN VIVO STUDY;
LUNG FIBROBLAST;
MALE;
MOUSE;
NONHUMAN;
PLASMA CLEARANCE;
PLASMA PROTEIN BINDING;
PRIORITY JOURNAL;
PROSTATE TUMOR;
SINGLE DRUG DOSE;
UMBILICAL VEIN ENDOTHELIAL CELL;
|
EID: 79952527357
PISSN: 20402503
EISSN: 20402511
Source Type: Journal
DOI: 10.1039/c0md00179a Document Type: Article |
Times cited : (14)
|
References (24)
|